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Abbreviations 
AA arachidonic acid 
ABCA1 ATP-binding cassette transporter A1 
ABCG1 ATP-binding cassette transporter G1 
acLDL acetylated LDL 
apo-AI apolipoprotein AI 
BiFC bimolecular fluorescence complementation 
CoA coenzyme A 
DAG diacylglycerol 
DHA docosahexaenoic acid 
EE early endosome 
EPA eicosapentaenoic acid 
ER endoplasmic reticulum 
EXO70 exocyst complex 70 
FFAT two phenylalanines in an acidic tract 
GFP green fluorescent protein 
GST glutathione-S-transferase 
HDL high-density lipoprotein 
HMG 3-hydroxy-3-methyl-glutaryl 
IL interleukin 
iNOS inducible nitric oxide synthase 
IP3 inositol trisphosphate 
KC ketocholesterol 
LD lipid droplet 
LE late endosome 
LPC lysophosphatidylcholine 
LPS lipopolysaccharide 
LTP lipid transfer protein  
LXR liver X receptor 
LY lysosome 
MCP-1 monocyte chemoattractant protein 1 
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MVB multivesicular body 
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NPC1 Niemann-Pick C1 
NUP62 nucleoporin p62 
NVJ nucleus-vacuole junction 
OHC hydroxycholesterol 
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ORP oxysterol binding protein related protein 
OSBP oxysterol binding protein 
oxLDL oxidized LDL 
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PC phosphatidylcholine 
PE phosphatidylethanolamine 
PE-pl PE plasmalogen 
PG phosphatidylglycerol 
PHD pleckstrin-homology domain 
PI phosphatidylinositol 
PIP phosphatidylinositol phosphate 
PL phospholipid 
PLC phospholipase C 
PLTP phospholipid transfer protein 
PM plasma membrane 
PMA phorbol myristate acetate 
PS  phosphatidylserine 
RILP Rab7 interacting lysosomal protein 
ROS reactive oxygen species 
shNT Non-Targeting shRNA 
shRNA short-hairpin RNA 
SM sphingomyelin 
SR scavenger receptor 
SREBP sterol regulatory element binding protein  
TAG triacylglycerol 
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Abstract 
All biological membranes consist of several types of lipids that have important 
structural and functional roles. Moreover, these lipids can act as signaling molecules 
or affect the function of cellular proteins. Regulation of lipid homeostasis is critical 
for the maintenance of cellular physiology, and disturbances in lipid metabolism 
aspects are key components behind many metabolic diseases, including 
atherosclerosis.  
 
Macrophage cells play central roles in the development of atherosclerosis. The 
excessive uptake of modified lipoprotein particles in the vessel subendothelial space 
results in a proinflammatory response and the formation of macrophage foam cells. 
Oxysterols, oxidized cholesterol derivatives that primarily are taken up along with 
the modified lipoproteins, act at the crossroads of lipid metabolism and 
inflammation, and are thus important signaling lipids involved in atherogenesis.   
 
In this thesis the functions of three members of the Oxysterol Binding Protein 
(ORP) Family have been studied. The ORP1L, ORP3, and ORP8 proteins are 
abundantly expressed in the macrophage cell type, and their endogenous role in 
macrophages was studied by knocking down the proteins individually using short 
hairpin RNA encoding lentiviruses. Moreover, the general function of these proteins 
was studied using other cell models.  
 
In the first part, the targeting of late endosomal protein ORP1L was investigated 
in HeLa cells. We show that ORP1L affects the motility and function of late 
endosomes in a sterol dependent manner. ORP1L is reported to mediate the 
interaction of late endosomes and endoplasmic reticulum, which restricts the 
motility of the endosomes. Furthermore, we show that cholesterol removal from 
macrophage foam cells is inhibited in the absence of ORP1L.  
 
In the second part the endogenous role of ORP8 in the macrophage was 
investigated by transcriptome, biochemical and functional assays. We show that 
ORP8 knockdown results in activation of several nuclear pathways as well as 
microtubule and centrosome organization pathways. We further provide evidence 
that ORP8 affects cellular migration dependent, in part, on its interaction with a 
nuclear pore complex component, Nucleoporin p62. Moreover, we demonstrate the 
impact of ORP8 knockdown on microtubule cytoskeleton, which is essential for many 
processes during migration. 
 
In the third part, the lipidome of macrophage cells subjected to ORP silencing is 
studied in four conditions relevant for atherogenesis: under basal conditions, or 
treated with oxidized or enzymatically modified lipoprotein preparations that are 
known to result in different lipid storage phenotypes, or stimulated with 
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lipopolysaccharide, which triggers inflammatory responses. The lipidome analysis 
revealed complex and profound changes in the cellular lipidome in the absence of 
ORPs, with implications for the inflammatory response.  
 
In addition, some unpublished data are presented regarding the subcellular 
targeting of ORP3 and ORP8 proteins.   
 
This work has provided information on the cellular functions of macrophage-
enriched ORP members, and revealed novel aspects in the function of the protein 
family in the cellular physiology. These data suggest that the modulation of ORP 
levels and/or function represents an attractive target for prevention or treatment of 
atherosclerosis.   
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Review of the literature  
2.1 Cellular lipid homeostasis 
2.1.1. Introduction to lipids  
Lipids are a heterogeneous group of biomolecules with a hydrophobic moiety. 
Majority of cellular lipids are present in biological membranes or in special lipid 
storage organelles. The main membrane lipid classes are glycerophospholipids, 
sterols and sphingolipids. These have important structural roles, but they also 
participate in many cellular events, as will be discussed in later sections.  
 
Glycerophospholipids (from now on referred to as phospholipids, PL) are the 
major structural lipids of eukaryotic membranes. The diacylglycerol (DAG) backbone 
of phospholipids carries two fatty acyl moieties at sn-1 and sn-2 positions (Figure 1). 
A phosphate group is bridging the DAG backbone to choline, ethanolamine, serine, 
inositol, or glycerol headgroups, thus forming phosphatidycholine (PC), 
phosphatidylethanolamine (PE), phosphatidylserine (PS), phosphatidylinositol (PI), 
or phosphatidylglycerol (PG) lipids, respectively (Figure 1). The fatty acyl moieties 
can vary greatly in the length (number of carbon atoms) and degree of unsaturation 
(number of double bonds in the carbon chain). There are thousands of possible 
combinations of head groups and fatty acyl moieties (Vance, 2008).  
 
The most abundant sterol in mammalian cells is cholesterol. Cholesterol molecule 
is a rigid and planar 4-ring structure with iso-octyl chain attached to carbon-17 
(Figure 1). It is an essential building block of cellular membranes, especially plasma 
membrane (PM) (Lange, 1991), affecting the membrane fluidity, impermeability and 
viscosity. In addition, cholesterol acts as precursor for several essential molecules, 
including steroid hormones, vitamin D, bile acids and oxysterols (chapter 2.1.5.3).  
The cellular amount of free cholesterol is tightly regulated, and excess cholesterol is 
stored in an esterified form in the cytoplasmic lipid droplets (LD).  
 
All sphingolipids, including sphingomyelins (SM), ceramides and 
glycosphingolipids, contain a sphingoid base, most often sphinganine. Sphingolipids 
are involved in maintaining the cellular structure, cell recognition, adhesion and 
signaling (Merrill et al., 2007). The most abundant sphingolipid class is SM (Figure 1) 
that serves both as precursors and end products in ceramide metabolism. 
Glycosphingolipids arise from addition of carbohydrate structures to the backbone, 
giving rise to a large amount of distinct sphingolipid molecules. The glycosylation is 
involved in cell interactions with the extracellular environment (Merrill et al., 2007).  
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Imbalances in lipid metabolism are a key component of several pathological 
states, including metabolic syndrome, obesity, cardiovascular diseases and type 2 
diabetes (Wymann and Schneiter, 2008). Moreover, upregulation of lipid metabolism 
is one of the early hallmarks of cancer (Kuhajda et al., 1994; Swinnen et al., 2000).  
Altogether, these diseases contribute to ever growing health problems in the western 
world, but also to an increasing extent in the developing countries.  
 
Figure 1. The structures of main membrane lipid classes: glycerophospholipids (PC here as an example), 
sphingomyelin, and cholesterol. The hydrophilic molecule moieties are highlighted in grey, and the 
hydrophobic moieties indicated on the left.  
2.1.2 Biological membranes 
 
Biological membranes form continuous barriers that surround the cell, nucleus 
and other cellular organelles. Membranes consist of a phospholipid bilayer, where 
other lipids and membrane proteins are embedded (Figure 2). In water, 
phospholipids spontaneously form bilayers or liposomes with the hydrophobic tails 
facing towards the bilayer or the liposome lumen, and the hydrophilic moieties 
facing out.  
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Figure 2. A schematic presentation of A) the lipid bilayer with proteins embedded, and B) the influence of 
a double bond within the acyl chain on the PL structure. Some figure components were provided by 
Servier Medical Art (www.servier.com).  
Biological membranes are highly dynamic structures. Many physiological 
processes, including cell growth, cell motility, endocytosis, exocytosis, and 
phagocytosis require active reshaping of membranes. Moreover, the lipid 
environment regulates the function of several membrane proteins, including 
membrane transporters, ion channels, and proteins involved in signal transduction.  
The regulated import/export of aqueous solutes and larger molecules, unable to 
passively across the membrane, is an important aspect of cellular homeostasis.   
 
The lipid composition defines dynamic properties of the membrane. The fluidity, 
resistance and curvature are determined by the lipid constitutions within the 
membrane: the relative amounts and leaflet asymmetry of lipid classes, their fatty 
acyl content, and lateral organization. The relative amounts of different lipids vary 
greatly between organelles and leaflets, and each organelle has a unique lipid 
composition (Figure 3), necessary for its function. It is, however, poorly understood 
how the compositions are achieved and maintained.  
 
 
Figure 3. Organelle distribution of different phospholipids, cholesterol, and sphingomyelin, diameters 
reflect contribution to total cellular lipid. Abbreviations: BMP, bis(monoacylglycero)phosphate; CL, 
cardiolipin; ER, endoplasmic reticulum; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PG, 
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phosphatidylglycerol; PI, phosphatidylinositol; PS, phosphatidylserine; SM, sphingomyelin. Adapted with 
permission from (van Meer and de Kroon, 2011).  
The lateral lipid organization is a constantly ongoing process, as the lipids move 
laterally relatively fast. Mainly hydrophobic forces guide it, and lipids tend to adopt 
an organization according to the principles of minimal energy (Somerharju et al., 
2009). Lipids are not uniformly distributed within the membrane, but form distinct 
domains that differ in their biophysical properties. The amount of cholesterol is 
critical for membrane fluidity, as cholesterol rigidifies all membranes by allowing 
tighter packing of surrounding PLs (Greenwood et al., 2006; Mouritsen and 
Zuckermann, 2004; Smaby et al., 1994), thus forming more ordered domains in the 
membrane. The size and shape of phospholipid molecules, defined by the headgroup 
and fatty acyls, regulate how tightly these lipids can be packed. Long and saturated 
acyl chains allow for tighter packing, whereas the fluidity increases with the degree 
of unsaturation of the acyls due to the kinks that double bonds introduce to the 
molecule (Figure 2).  
 
Cholesterol has a tendency to associate with SM, and membranes enriched in 
these lipids (such as PM) can form specialized microdomains called lipid rafts. Rafts 
form platforms for membrane proteins, important in membrane transport and 
signaling (Hancock, 2006; Lingwood and Simons, 2010).  
2.1.3 Cellular lipid trafficking 
Due to their hydrophobic nature, lipids cannot move freely between cellular 
compartments. To maintain correct lipid compositions of membranes, tightly 
controlled mechanisms for lipid transport have developed. In general, lipid transport 
can be mediated by vesicular and non-vesicular mechanisms.   
2.1.3.1 Non-vesicular trafficking  
It has been estimated that majority of cholesterol transport occurs by non-
vesicular routes (Ikonen, 2008). Non-vesicular cholesterol transport is mediated by 
different families of lipid transfer proteins (LTPs), soluble proteins with lipid binding 
cleft or tunnel that can shuttle the lipid between membranes (D'Angelo et al., 2008). 
Recently, involvement of membrane contact sites (MCS) in the non-vesicular lipid 
transfer has been suggested. These are zones where the membranes of two 
organelles are in a very close proximity (within 10-30 nm), allowing for more 
efficient lipid transport between the compartments (Levine and Loewen, 2006; 
Toulmay and Prinz, 2011). At these sites, lipid transfer can occur by action of LTPs or 
by integral membrane proteins. MCSs are described in further detail in section 2.3.6.  
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2.1.3.2 Vesicular trafficking  
Vesicular trafficking is involved in transport of proteins and lipids between 
cellular compartments. The transport is controlled at multiple levels to ensure 
correct localization of biomolecules, and proper membrane composition and 
function. Vesicular transport assures proper lipid and protein compositions of 
organelles, essential for their function. Moreover, accurate targeting of transport 
material is necessary to prevent possibly harmful mixing of organelle constituents. 
Secreted and membrane proteins and majority of lipids are synthesized in the 
endoplasmic reticulum (ER), and further post-translational modification of proteins 
takes place in the Golgi apparatus. From their site of synthesis, molecules are 
transported to final destinations by vesicular transport (Bonifacino and Glick, 2004, 
Mellman and Warren, 2000). Vesicular transport is also involved in the trafficking 
and handling of internalized (endocytosed or phagocytosed) materials. Moreover, 
cellular migration uses vesicular transport machinery to provide membrane material 
to dynamically reshape the cell's leading edge (Kriebel et al., 2008).  
 
Vesicular trafficking begins with coat assembly and sorting of the cargo material. 
Formed vesicles then bud off from the donor compartment, followed by the vesicle 
transport along cellular cytoskeleton tracks (microtubules) with the help of motor 
proteins, myosins, kinesins and dyneins (Lippincott-Schwartz, 1998). Vesicle 
tethering and fusion with the recipient membrane is mediated by SNARE (soluble N-
ethylmaleimide-sensitive fusion protein attachment) proteins (Bonifacino and Glick, 
2004). Finally, the membrane-associated and/or luminal cargo is released to the 
target organelle (Olkkonen and Ikonen, 2000). Rab GTPases regulate multiple steps 
of vesicular transport, including tethering and docking, fusion, and motor protein 
recruitment (Pfeffer, 2001).  
2.1.3.3 Endocytosis and phagocytosis 
Endocytic machinery is responsible for the "inward" vesicle trafficking, following 
internalization of soluble materials, lipids, macromolecules and other particles 
(Huotari and Helenius, 2011). After cargo binding and/or selection, primary 
endocytic vesicles first deliver their cargo to early endosomes (EE) where molecules 
are primarily sorted. Proteins to be reutilized (receptors and SNARE proteins, for 
example) are recycled back to the PM via recycling endosomes or transported to 
trans-Golgi network (Bonifacino and Rojas, 2006).  
 
Endosomes containing molecules targeted for degradation mature (or are 
delivered) to late endosomes (LE), multivesicular bodies (MVB), and lysosomes (LY). 
As the endosomes mature and move towards the cell center, their luminal pH 
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gradually decreases, internal membranes appear, and the membrane composition 
changes. While a high content of phosphatidylinositol 3-phosphate (PI3P) and Rab5 
are markers for EEs, Rab7 and PI(3,5)P2 in turn are enriched in LE membranes 
(Vicinanza et al., 2008). The increased LBPA (lysobisphosphatidic acid) content and 
decreased pH of LE has been suggested to contribute to the appearance of internal 
vesicles and membranes of LE (Matsuo et al., 2004). Finally, degradation of 
endocytosed material occurs at the low pH of lysosomes.  
 
Phagocytosis is an endocytic process for internalization of larger particles, 
including pathogens, apoptotic cells or cell debris, and it is an important defense 
mechanism performed by specialized cell types, including monocytes, macrophages, 
and neutrophils (Conner and Schmid, 2003).  Receptor binding at the cell surface 
triggers a signaling cascade that initiates actin-driven plasma membrane extension 
formation, followed by engulfment of the particle and formation of a phagosome. The 
phagosome fuses with endosomes and lysosomes in the cytosolic compartment, 
followed by enzymatic digestion of the engulfed material (Stuart and Ezekowitz, 
2005). As phagocytosing cells are able to engulf relatively large particles compared 
to their cell size, it is evident that dynamic reshaping of the membrane is needed in 
the process. Although it is not clear where the extra material originates, ER has been 
suggested to provide extra membrane (Touret et al., 2005). Similar to endosomal 
maturation, the membrane lipid composition changes during phagosome maturation 
(Steinberg and Grinstein, 2008).   
 
2.1.4 Cellular lipid storage 
An excess amount of free cholesterol is toxic to cells. Cellular cholesterol levels 
are dependent on several processes, including the uptake of cholesterol from 
extracellular compartments, cholesterol biosynthesis, and efflux. These processes are 
tightly regulated by several feedback mechanisms.  
 
Cells are able to synthesize cholesterol from the ubiquitous precursor, acetyl-
coenzyme A (acetyl-CoA) by a series of 30 enzymatic reactions. The cholesterol 
biosynthetic pathway, described already in 1964 (Bloch, 1965), begins with the 
synthesis of 3-hydroxy-3-methylglutaryl (HMG-CoA), followed by its reduction by 
HMG-CoA reductase. This rate-limiting, early step in cholesterol biosynthesis is the 
target of statins, drugs commonly used in lowering blood cholesterol levels to 
prevent/treat cardiovascular diseases.  
 
Another way to acquire cholesterol by cells is from extracellular sources, mainly 
in the form of low-density lipoprotein (LDL). LDL uptake is initiated by binding to 
LDL receptors at the cell surface, followed by its internalization in clathrin coated 
pits and formation of vesicles that are transported to endosomes and lysosomes 
  
 
 
 
Review of the literature 
 
  
16 
(Brown and Goldstein, 1986). The amount of LDL uptake depends on the abundance 
of cellular receptors, which is regulated by a feedback loop by sterol regulatory 
element binding protein (SREBP) transcription factors. The activity of the pathway is 
regulated by changes in cellular sterol levels. LDL receptor and other SREBP targets 
are upregulated when cellular cholesterol levels are low, allowing the cell to take up 
more cholesterol (Brown and Goldstein, 1997), which is another central aspect of 
statin function. Other important regulators of cellular cholesterol levels are liver X 
receptor (LXR) transcription factors. LXRs bind oxysterols and upregulate genes 
involved in reverse cholesterol transport, a process in which cholesterol is 
effluxed/taken up from peripheral cells and transported to the liver for excretion 
(Tontonoz and Mangelsdorf, 2003).  
 
Macrophages are also able to take up LDL particles containing oxidized or 
enzymatically modified lipids by scavenger receptors. Excessive uptake together 
with inefficient clearance of modified LDL particles results in accumulation of lipids 
in macrophages and the formation of foam cells. The significance of this process is 
further described in section 2.2.2.  
 
The cholesteryl esters (CEs), derived from the internalized LDL, are first 
hydrolyzed in the lysosomal compartments by lysosomal acid lipase. The free 
cholesterol then exits lysosomes in a process mediated by Niemann-Pick C proteins 
NPC1 and NPC2, and is transported to PM and/or ER. The oxysterol binding protein 
(OSBP) related protein 5 (ORP5) has been implicated in the transport of cholesterol 
from lysosomes to the ER (Du et al., 2011). In the ER, cholesterol is re-esterified by 
acyl-coenzyme A:cholesterol acyltransferase (ACAT) enzymes (Chang et al., 1995). 
The re-esterified cholesterol is then stored in lipid droplets (LD).  
 
Lipid droplets are dynamic lipid and fatty acid storage organelles with a poorly 
understood function. They consist of a hydrophobic core of neutral lipids, including 
CE and triacylglycerols (TAG), surrounded by a monolayer of phospholipids. Several 
LD-associated proteins have been described. These include structural proteins (such 
as perilipins), proteins involved in lipid homeostasis (for example adipose 
triglyceride lipase ATGL), and proteins involved in membrane trafficking (including 
Rab proteins) (Guo et al., 2009). Interestingly, ORP2 has been shown to associate 
with LD in a sterol-dependent manner, and to regulate TAG and CE metabolism 
(Hynynen et al., 2009).  
  
Upon demand, cholesterol and fatty acids can be mobilized from LD. Excessive 
lipid storage in LD plays a central role in the pathogenesis of several metabolic 
diseases, including obesity, diabetes and atherosclerosis. Reverse cholesterol 
transport is the only way for non-hepatic cells to get rid of cholesterol.  This reverse 
cholesterol transport pathway is further discussed in section 2.2.1  
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2.1.5 Lipid signaling 
It is becoming evident that, in addition to being cellular building blocks and 
energy reservoirs, lipids are also heavily involved in maintaining cellular 
homeostasis. Certain lipids can mediate or act as precursors for biological signaling. 
Due to the fact that lipids reside in membranes, lipid messengers are not stored but 
rather produced on demand at the site of intended action. Here, I will discuss the role 
of some lipids with signaling functions, which are in the scope of the research 
conducted in this thesis.   
2.1.5.1 Phosphatidylinositol phosphates as lipid mediators 
Phosphatidylinositol phosphates (PIPs) play central roles in signal transduction, 
membrane trafficking, cell migration and polarization, actin cytoskeleton remodeling, 
and sphingolipid metabolism (Saarikangas et al., 2010; Vicinanza et al., 2008). They 
are constantly phosphorylated and dephosphorylated by specific kinases and 
phosphatases resulting in seven distinct types of PIPs. These are enriched in specific 
organelle membranes (Table 1) and act as organizers controlling the 
recruitment/activation of target proteins (Vicinanza et al., 2008). Moreover, they can 
act as precursors for second messengers.  
 
Table 1. Enrichment of differenct PIP species at cellular organelles of vesicular trafficking (Vicinanza et al., 
2008). Abbreviations: LE, late endosome; MVB, multivesicular body; PIP, phosphatidyl inositol phosphate; 
PM, plasma membrane; TGN, trans-Golgi network.  
PIP species Organelle  
PI(3)P Early endosomes, MVB internal vesicles, phagosomes 
PI(4)P Golgi complex (TGN) 
PI(5)P Cytoplasmic membranes 
PI(3,4)P2 PM 
PI(3,5)P2 LE (outer membrane) 
PI(4,5)P2 PM, clathrin coated pits, Golgi complex,  
PI(3,4,5)P3 PM (generated in response to extracellular stimuli) 
 
In response to ligand (e.g. hormones or growth factors) binding, G protein-
coupled receptors activate cellular phospholipase C (PLC) that cleave PIP2 into 
inositoltrisphosphate (IP3) and DAG, both of which act as second messengers 
(Smrcka et al., 2012). IP3 binds to IP3 receptors in the ER and triggers the release of 
Ca2+ to the cytoplasm. DAG, in turn, binds and activates protein kinase C (PKC) to 
control variety of cellular processes (Figure 4).  
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Figure 4. The cleavage of PIP2 at the plasma membrane by PLC yields second messengers: IP3 triggers 
release of Ca2+ from the ER, DAG in turn activates PKCs. Some figure components were provided by 
Servier Medical Art (www.servier.com). 
2.1.5.2 Inflammatory lipid mediators 
Eicosanoids are potent signaling molecules involved in the inflammatory 
response (Buczynski et al., 2007; Ma et al., 2012; Wymann and Schneiter, 2008). 
Polyunsaturated fatty acids, primarily arachidonic acid (AA; 20:4, n-6), 
eicosapentaenoic acid (EPA, 20:5 n-3), and docosahexaneoic acid (DHA, 22:6 n-3) are 
the precursors used in the synthesis of eicosanoids. Eicosanoid precursors are 
released from phospholipids or DAGs by PLA2 (phospholipase A2) to produce 
leukotrienes, prostaglandins, thromboxanes, prostacyclins (collectively eicosanoids), 
and resolvins (non-classical eicosanoids) by the action of lipoxygenases (LOX), 
cycloxygenases (COX), and cytochrome P450 family members (Lawrence et al., 
2002).  
 
In response to cytokine stimulation, mechanical trauma, or Toll-like receptor 
(TLR) activation and subsequent rise in cellular Ca2+ (Buczynski et al., 2007), 
eicosanoid production and secretion is stimulated (Astudillo et al., 2012). 
Eicosanoids derived from n-6 fatty acids (e.g. AA) are proinflammatory by nature, 
whereas the eicosanoids produced from n-3 precursors (DHA, EPA) are 
counteracting (resolving) these effects (Lawrence et al., 2002; Lee, 2012). 
Proinflammatory actions of eicosanoids include fever generation, pain responses, 
leukocyte adhesion and activation, and chemotaxis (Astudillo et al., 2012).  Resolvins, 
on the other hand, function to dampen these inflammatory responses, and by 
inhibiting leukocyte recruitment and cytokine release (Lee, 2012).  
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It has been shown that increased eicosanoid levels are associated with 
pathological disorders including metabolic syndrome and atherosclerosis (Horrillo et 
al., 2010; Sanchez et al., 2010). Additionally some sphingolipids, including ceramides 
and sphingosines, as well as lysophospholipids (lyso-PL) are generally regarded as 
proinflammatory. For example, higher levels of ceramides (Adams et al., 2004) and 
lyso-PL (Pietiläinen et al., 2007) have been associated with inflammatory conditions 
such as obesity. Ceramides and sphingosines have pro-apoptotic and anti 
proliferative effects (Taha et al., 2006). Lyso-PC (LPC) are activators of G-protein 
coupled receptors to regulate migration and calcium homeostasis (Meyer zu 
Heringdorf and Jakobs, 2007).  
2.1.5.3 Oxysterols 
Oxysterols are oxygenated derivatives of cholesterol that rise from both 
enzymatic and non-enzymatic reactions. The common oxidative modifications 
include hydroxyl, keto, epoxy, and carboxyl moieties that render the resulting 
molecule less hydrophobic than cholesterol and thus more easily transportable 
(Björkhem and Diczfalusy, 2002; Javitt, 2008; Schroepfer, 2000). In biological 
membranes, oxysterols may impact on membrane lipid packing and lipid draft 
assembly. Moreover, oxysterols have been reported to impair activity of membrane 
ion channels (Duran et al., 2010).  
 
Increased oxysterol concentrations have cytotoxic properties (Lordan et al., 
2007). However, in physiological concentrations these compounds are potent 
regulators of cellular cholesterol homeostasis (Gill et al., 2008), and are implicated at 
the crossroads of lipid metabolism and inflammation in macrophages (Shibata and 
Glass, 2009, 2010).  
 
In normal conditions, oxysterol concentrations are minute compared to 
cholesterol, but are elevated in certain pathological situations, such as 
atherosclerosis, diabetes and obesity (Alkazemi et al., 2008; Murakami et al., 2001, 
Vaya et al., 2001). Several factors contribute to the cellular oxysterol content, 
including cholesterol biosynthesis and uptake of oxidized lipoproteins. Oxysterols 
arise from enzymatic reactions by mitochondrial or ER cholesterol hydroxylases 
(Russell, 2000). One of the abundant oxysterols, 25-hydroxycholesterol (25-OHC), is 
secreted by macrophages in response to TLR4 activation (Bauman et al., 2009). 
Moreover, cholesterol can be autooxidized, for example by action of reactive oxygen 
species (ROS) or lipid peroxides (Brown and Jessup, 1999).  The most important 
oxysterols arising from cholesterol autoxidation are the 7β-hydroxycholesterol and 
7-ketocholesterol (7-KC) (Lordan et al., 2007).  
 
Oxysterol signals are mediated by several cellular effectors with variable 
downstream outcomes. Nuclear LXR transcription factors, activated by oxysterols 
  
 
 
 
Review of the literature 
 
  
20 
(Janowski et al., 1996), upregulate genes involved in the cholesterol efflux, transport, 
and excretion (Tontonoz and Mangelsdorf, 2003). Moreover, LXRs negatively 
regulate macrophage inflammatory gene responses by inhibiting expression of 
nuclear factor kappa B (NF-κB) activated genes, including interleukin-1β (IL-1β), 
incucible nitric oxide synthase (iNOS), and monocyte chemoattractant protein-1 
(MCP-1) (Joseph et al., 2003). Oxysterols regulate yet another transcriptional 
machinery involved in lipid homeostasis, namely SREBPs. The insulin induced gene 
(Insig) proteins were found to bind 25-OHC to regulate SREBP processing, thereby 
blocking SREBP transport and inhibiting cholesterol biosynthesis (Radhakrishnan et 
al., 2007; Sun et al., 2007b). Other proteins with reported oxysterol affinity include 
the late endosomal/lysosomal cholesterol transfer protein NPC1 (Infante et al., 
2008), estrogen receptors (Umetani et al., 2007), a putative cholesterol transfer 
protein StarD5 (Soccio et al., 2005), The retinoic acid receptor-related orphan 
receptors (RORα/γ) (Wang et al., 2010), Epstein-Barr virus-induced gene 2 EBI2 
(Hannedouche et al., 2011; Liu et al., 2011), and oxysterol binding protein family 
(ORPs), which are discussed in detail in section 2.3.  
2.2 Macrophages  
Macrophages are phagocytic cells that function both in the innate and adaptive 
immunity. They derive from blood monocytes, and circulate in the blood until 
recruited to sites of inflammation, followed by differentiation into macrophages or 
dendritic cells according to the environmental signals (Gordon and Taylor, 2005). 
Macrophages contribute to the early host defense mechanism by phagocytosing 
harmful or foreign material, followed by antigen presentation at their cell surface 
that can be recognized by other inflammatory cells. Moreover, activated 
macrophages recruit other cells of the inflammatory system by release of 
inflammatory mediators.  
 
Macrophages are abundantly present at sites of inflammation, in the liver (so 
called Kupffer cells), in the white adipose tissue, the intestine, the lung, and the 
spleen. They are also present already from the early stages of atherosclerotic lesion 
development, having central role in the lesion development. 
 
Macrophages are able to internalize massive amounts of lipids. They have an 
important role in clearing accumulated or damaged lipids from tissues, including the 
subendothelial space of blood vessels (see section 2.2.2). Macrophages are active in 
reverse cholesterol transport, a process where accumulated lipid from peripheral 
tissues is delivered to high-density lipoprotein (HDL) particles, to be excreted from 
the body by the liver (Rader et al., 2008). 
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The initial step in the reverse cholesterol transport is the mobilization of CEs from 
LDs, either by neutral hydrolases or autophagosomal degradation of lysosomal 
compartments (Ouimet and Marcel, 2012). Cholesterol is then transported to 
extracellular cholesterol acceptors by the action of ATP-binding cassette (ABC) 
transporters, to lipid-poor apolipoprotein-AI (apo-AI) particles by ATP-binding 
cassette transporter A1 (ABCA1) or to spherical HDL2 particles by ATP-binding 
cassette transporter G1 (ABCG1) (Rader et al., 2008). The resulting HDL particles 
circulate to the liver, and the cholesterol they contain is excreted as cholesterol or as 
converted to bile acids.  
 
Macrophages are characterized by active and fast changes in their morphology. 
The activation of macrophages changes the round morphology of monocytes into 
amoeboid phenotype (Porcheray et al., 2005), a process that requires active 
reshaping of cellular cytoskeleton and lipid membranes. Moreover, cell migration, 
phagocytosis, and infiltration through endothelium are accompanied by dynamic 
changes in membrane organization and cell shape.  
 
2.2.1 Inflammatory actions of macrophages 
Macrophages express several pattern recognition receptors in their cell surface, 
including TLR and scavenger receptors (SR) (Binder et al., 2002). The ligand binding 
can result in macrophage activation or internalization of the ligand. SRs, including 
CD36, SR-B1 and SR-A, recognize modified LDL, including oxidized LDL (oxLDL), and 
are involved in the internalization of these particles (Sun et al., 2007a).  
 
There are at least ten TLRs in mammalian organisms, with diverse specificity for 
endogenous and exogenous ligands (Medzhitov, 2001). For example, TLR2 is 
activated by components of Gram-positive bacteria (Yang et al., 1998), whereas 
Gram-negative components are recognized by TLR4 (Chow et al., 1999). Moreover, 
TLR activation can be triggered by free fatty acids (Shi et al., 2006) and necrotic cells 
(Li et al., 2001). Proinflammatory TLR activation at the cell surface regulates 
transcription of cytokines, chemokines, iNOS and ROS via activation of NF-κB or 
interferon regulatory factor 3 (IRF3) pathways (Castrillo et al., 2003; Li et al., 2001; 
Thoma-Uszynski et al., 2001).  
 
Depending on the activating signals, monocyte-macrophages are polarized into 
M1 or M2 type of macrophages with different functional properties. Classically 
activated M1 macrophages are characterized by increased microbicidal capacity, 
together with increased secretion of proinflammatory cytokines, which further 
increases the local immune response (Gordon and Taylor, 2005, Gordon, 2007). 
Classical activation is triggered by pro-inflammatory cytokines, such as interferon-
gamma (IFNγ) or tumor necrosis factor-alpha (TNFα), or by recognition of foreign 
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material, such as bacterial lipopolysaccharide (LPS). On the other hand, anti-
inflammatory cytokines, including transforming growth factor beta (TGFβ), IL4, IL10 
and IL13, may trigger alternative macrophage activation. These M2-polarized 
macrophages are involved in the resolution of inflammation and tissue repair 
(Gordon and Taylor, 2005). Interestingly, saturated fatty acids are reported to 
promote M1 response (Holland et al., 2011; Nguyen et al., 2007; Shi et al., 2006), 
while unsaturated fatty acids promote M2 macrophage response (Serhan, 2009). 
 
Another key inflammatory function of macrophages is phagocytosis and killing of 
pathogens (see section 2.1.3.3). Phagocytic receptors, including TLR and scavenger 
receptors, recognize foreign particles, which leads to their engulfment and 
subsequent lysosomal degradation of the particles (Stuart and Ezekowitz, 2005).  
2.2.2 Role of macrophages in the development of atherosclerosis 
As discussed in the preceding sections, macrophages function at the crossroads of 
lipid metabolism and inflammation. In several lipid metabolism disorders, including 
metabolic syndrome, obesity and atherosclerosis, the presence of chronic 
inflammation is recognized as a key component (Libby, 2002; Ma et al., 2012).  
 
Macrophages play key roles in the initiation and progression of atherosclerotic 
lesions; they are present already in fatty streaks, the early lesion manifestation. 
Inflammation (MCP-1) and cholesterol (oxLDL) accumulation into vessel walls 
promote recruitment and infiltration of macrophages in the subendothelial space. 
Native and modified (oxidized) LDL particles are taken up by macrophage SRs in 
excessive amounts, and stored in LDs as CE. As a response, LXR mediated activation 
of cholesterol efflux attempts to compensate for the lipid overload. Additionally, 
macrophages recruit more inflammatory cells to the site by secreting inflammatory 
mediators (Joseph et al., 2003). The overload of the macrophage cholesterol removal 
capacity results in transformation of macrophages to foam cells, where the cell is 
characteristically full of LDs. As a result of excessive lipid uptake, foam cells may 
undergo apoptosis, resulting in a necrotic core and more advanced lesions (Glass and 
Witztum, 2001).  
 
Interestingly, some reports suggest that macrophages are also able to migrate out 
of the lesion, which results in lesion regression (Daoud et al., 1981; Llodra et al., 
2004). Binding of oxLDL to CD36 scavenger receptors was recently suggested to 
mediate this emigration event (Park et al., 2009). In that study, CD36 was shown to 
modulate cellular cytoskeletal dynamics upon oxLDL binding, thereby negatively 
regulating emigration. OxLDL binding activated a signaling cascade involving 
activation of Src kinases and FAK, promoting cell spreading and macrophage 
entrapment. Moreover, LXR mediated upregulation of the chemokine receptor CCR7 
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was shown to increase emigration of macrophages from atherosclerotic plaques 
(Feig et al., 2010).  
  
Oxysterols, important regulators of macrophage homeostasis, may have key roles 
in the lesion development. The uptake of modified lipoproteins by macrophages is a 
major cellular source of oxysterols, and their significant enrichment has been shown 
to exist in atherosclerotic plaques (Garcia-Cruset et al., 2001). Moreover, 
macrophage activation by TLR signaling has been shown to increase 25-OHC 
production (Bauman et al., 2009). Oxysterols are potent regulators of lipid 
homeostasis and inflammatory processes (above and chapter 2.1.5.3). Oxysterol 
effects are partly mediated by the cytosolic oxysterol binding protein family, the 
topic of this thesis. The protein family is described in detail in the following sections.   
2.3 Oxysterol binding proteins 
The oxysterol binding protein (OSBP) family is conserved in the eukaryotic 
kingdom. In addition to mammalian organisms, homologues of OSBP-related proteins 
(ORP) have been identified in yeast, insects, plants, and worms (Alphey et al., 1998; 
Avrova et al., 2004; Beh and Rine, 2004; Kobuna et al., 2010; Skirpan et al., 2006; 
Sugawara et al., 2001), practically in all organisms for which sequence information is 
available. The studies on yeast ORP homologues (called Osh1-7) have played a 
pioneering role in understanding the ORP structure and function (Beh and Rine, 
2004; Raychaudhuri and Prinz, 2010).  
 
In mammals, including humans, 12 OSBPL genes encode for ORP proteins (Figure 
5). The number of distinct ORP proteins is, however, much higher than this. Short 
("S") and long ("L") variants of some gene products (ORP1S and ORP1L, for example) 
arise from different promoters (Jaworski et al., 2001; Wang et al., 2002), which differ 
in expression pattern, subcellular localization and function (Johansson et al., 2003). 
Moreover, at least eight splice variants of ORP3 have been identified (Collier et al., 
2003), highlighting the enormous variability within the protein family.  
 
In general, ORPs differ from one another in their expression pattern, subcellular 
localization and substrate specificity. Each tissue and cell type expresses a 
characteristic pattern of ORPs at different quantities (Lehto et al., 2001). The 
magnitude of ORP homologues in different organisms together with their ubiquitous 
expression suggests a fundamental role of these proteins in the cellular physiology.  
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2.3.1 ORP structure 
Several characteristic domains are present in a majority of ORPs (Figure 5). A 
common feature present in all members is an OSBP related domain (ORD), which 
contains an OSBP fingerprint motif EQVSHHPP. The ORD structure has been 
determined in complex with several sterols (Im et al., 2005). The structure consists 
of anti-parallel β-sheets that fold into a barrel-like structure with a hydrophobic core 
capable of accommodating one lipid molecule at a time, accompanied by a flexible lid 
which protects the bound lipid molecule from the aqueous environment (Figure 6). 
 
The long ORP variants contain an N-terminal extension with multiple functional 
domains, including pleckstrin homology domain (PHD), ankyrin repeats ANK, and 
two phenylalanines in an acidic tract (FFAT) motif (Figure 5). The PHDs bind to PIPs 
on cellular membranes, and often mediate the subcellular targeting of the proteins 
(Levine and Munro, 1998; Ngo and Ridgway, 2009). The FFAT motif is a short 
sequence that binds to integral ER vesicle associated membrane protein-associated 
proteins (VAP). Interestingly, this motif is also present in other proteins involved in 
lipid metabolism, including lipid and PI transfer proteins (Loewen et al., 2003), most 
likely due to the central role of ER in lipid homeostasis. Some ORPs lacking the FFAT 
motif contain a C-terminal ER-anchoring transmembrane segment (Du et al., 2011; 
Yan et al., 2008). The ankyrin repeats, typically mediating protein-protein 
interactions (Li et al., 2006), have been shown to interact with active form of Rab7 in 
the case of ORP1L (Johansson et al., 2005), or to target the protein to nucleus-vacuole 
junction (NVJ) in the case of Osh1p (Kvam and Goldfarb, 2004). The significance of 
multiple domains involved in protein targeting present in ORPs is further discussed 
in section 2.3.6.  
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Figure 5. The mammalian ORP protein family with the major structural elements identified. Based on 
their amino acid secuences, the proteins are divided into 6 subfamilies, indicated on the right. The 
domains and motifs are color-coded: PHD in green; FFAT motif in black; OF (oxysterol binding protein 
”fingerprint” sequence) in yellow; ORD in orange; ankyrin repeats (ANK) in purple; trans-membrane 
segment (TM) in turquoise. See text for more detailed description of the motifs. 
 
 
 
Figure 6. ORP1L ORD as a representative example of the sterol binding fold. The structure is modeled in 
complex with 25-OHC using Osh4p as template (Im et al., 2005). Oxysterol molecule (in grey) is bound in 
the barrel-like pocket formed by beta strands, and the alpha-helical lid of the pocket is shown in dark 
blue. The color spectrum of the protein indicates the amino acid positioning; ranging from blue (N-
terminal) to red (C-terminal). 
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2.3.2 ORP ligands 
Osh4p was demonstrated by X-ray crystallographic analysis to bind cholesterol, 
ergosterol (main sterol in yeast), and several oxysterols (Im et al., 2005). Apart from 
the 3-hydroxyl group (facing towards the pocket bottom of the binding pocket), no 
interaction with the sterol hydroxyl groups and the protein were found. The pocket 
is thus able to accommodate a variety of sterols, showing a relatively low degree of 
ligand specificity. 
 
Several mammalian ORPs have been shown to bind oxysterols and cholesterol in 
vitro. Live cell photo-cross-linking with [3H]photo-25-OHC and [3H]photo-cholesterol 
suggested that all ORPs are able to bind sterols in vitro (Suchanek et al., 2007). This 
finding has been confirmed for several ORPs (OSBP, ORP2, ORP4, ORP8, ORP9, 
ORP10) (Hynynen et al., 2009; Ngo and Ridgway, 2009; Suchanek et al., 2007, Wang 
et al., 2002; Wang et al., 2008; Yan et al., 2007a, 2008; E.Nissilä and V.Olkkonen, 
unpublished) in sterol binding assays employing purified proteins. These studies 
have revealed differences in the binding affinities for oxysterols between ORPs. 
Moreover, a higher affinity for oxysterols than cholesterol was demonstrated for 
OSBP and ORP4 (Wang et al., 2008; Wyles et al., 2007). Cholesterol binding has been 
verified for all ORPs tested so far, whereas no oxysterol binding has been observed 
for certain ORPs (Ngo and Ridgway, 2009; E. Nissilä and V. Olkkonen, unpublished). 
The ORD is also able to accommodate other ligands besides sterols. A recent study 
(de Saint-Jean et al., 2011) showed that, PI4P could substitute the sterol bound in the 
Osh4p pocket. In addition, sterol-resembling small molecular inhibitors of ORPs 
(ORPhilins, (Burgett et al., 2011)) were shown to compete for 25-OHC binding, 
suggesting their capacity to bind to the ligand binding pocket.  
 
All ORPs are likely capable of binding several types of ligands. Depending on the 
ligand bound, the functional consequences could be different. For example, while 
binding of cholesterol to OSBP induces assembly of a protein phosphatase complex 
active on the extracellular signal regulated kinases (ERK), the complex is 
disassembled when 25-OHC binds to OSBP (Wang et al., 2005; Wang et al., 2008). 
Moreover, the localization of ORP2 in lipid droplets is inhibited by its oxysterol 
ligand, 22(R)-OHC (Hynynen et al., 2009). These findings suggest that cholesterol is a 
physiological ligand for all ORPs, and the more abundant availability of cholesterol 
could compensate for its weaker affinity for ORPs.  
2.3.3 The role of ORPs as modulators of lipid homeostasis 
Beh et al. showed in 2001 that disruption of all 7 yeast OSH genes was lethal, 
suggesting a common essential function for these proteins (Beh et al., 2001). They 
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later showed that disruption of OSH function altered intracellular sterol-lipid 
distribution, caused vacuolar fragmentation and accumulation of lipid droplets in the 
cytoplasm (Beh and Rine, 2004). These studies suggested that OSH genes affected 
intracellular sterol distribution, linking their depletion to multiple cell functions.  
 
In addition, several impacts in lipid homeostasis by mammalian ORPs (OSBP, 
ORP1L, ORP2, ORP5, ORP8, and ORP10) have been demonstrated. Upon 25-OHC 
stimulation, OSBP recruits ceramide transfer protein (CERT) to Golgi and thereby 
controls the transfer of ceramides from ER to Golgi for SM synthesis (Banerji et al., 
2010, Perry and Ridgway, 2006), a process regulated by protein kinase D mediated 
phosphorylation of OSBP (Nhek et al., 2010). Moreover, OSBP has been shown to 
modify ABCA1 stability (Bowden and Ridgway, 2008), and OSBP overexpression was 
shown to enhance lipogenesis and VLDL secretion in mice (Yan et al., 2007b).  
 
ORP1L overexpression in macrophages reduced cholesterol efflux to HDL and 
increased the size of atherosclerotic lesions in a mouse model (Yan et al., 2007a). 
Silencing of ORP2, which endogenously localizes to LD in an oxysterol-dependent 
manner, stabilizes cellular triglycerides (Hynynen et al., 2009). Cholesterol 
accumulation in late endosomal compartments appears in cells silenced for ORP5 
(Du et al., 2011). Furthermore, ORP8 overexpression in the mouse liver reduces 
cholesterol, triglyceride, and phospholipid levels in plasma and the liver tissue by 
downregulating the activity of SREBP (Zhou et al., 2011).  
 
These examples suggest pleiotropic effects for ORPs in the control of lipid 
homeostasis. The mechanisms, however, are poorly understood for other members 
than OSBP.   
 2.3.4 Are ORPs lipid carriers or sensors? 
The structure of the ligand binding pocket, very likely present on all ORPs, is 
characteristic for all lipid transfer proteins. The structure allows the accommodation 
of one lipid molecule at a time in a pocket closed by a lid, and transport of this 
hydrophobic molecule through aqueous environment (D'Angelo et al., 2008). Such a 
lipid carrier function has been suggested as the common property of ORPs. Indeed, 
several Osh and ORP proteins have been shown to transfer lipids in vitro (Du et al., 
2011; Ngo and Ridgway, 2009; Raychaudhuri et al., 2006).  
 
The initial evidence for ORP sterol binding was a study demonstrating the 
capacity of Osh4p to facilitate the nonvesicular transfer of cholesterol and ergosterol 
from PM to ER (Raychaudhuri et al., 2006). The investigators also observed a drastic 
reduction in PM to ER sterol transfer in cells deficient of all Osh proteins. Moreover, 
involvement of ORP proteins in transfer of newly synthesized cholesterol from ER to 
PM (Sullivan et al., 2006) has been suggested. These studies, however, provide no 
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solid evidence for a sterol carrier function. A recent report (Georgiev et al., 2011) 
suggests that the ORP effect in sterol transfer is indirect, and possibly results from 
altered membrane sterol organization which, in turn, is mediated by ORPs. 
Interestingly, Osh4p was recently shown to exchange bound sterol 
(dehydroergosterol) for PI4P and transport the two lipids between membranes 
along opposite routes (de Saint-Jean et al., 2011).  
 
Jansen et al. (Jansen et al., 2010) were the first to show an effect for mammalian 
ORPs in the intracellular cholesterol transfer. Using an assay to monitor the 
transport of Bodipy-labeled cholesterol from PM to LD, they showed that out of all 
human ORPs, overexpression of ORP1S or ORP2 stimulated cholesterol transfer. For 
ORP2 functional sterol binding was shown to be necessary for the observed effect. 
The study supports the role of ORPs in sterol transfer but does not provide 
conclusive evidence for a sterol carrier function, similar to Osh proteins. Other 
mechanisms might be their involvement in MCS (see section 2.3.6), or modulation of 
membrane lipid composition to enhance sterol transport by ORPs, as earlier 
suggested (Georgiev et al., 2011; Sullivan et al., 2006).  
 
On the other hand, instead of lipid transfer, ORP sterol binding could execute 
regulatory functions. Several observations support the role of ORPs as sterol sensors. 
First, changes in subcellular localization in response to ligand binding have been 
demonstrated for OSBP (Ridgway et al., 1992) and ORP2 (Hynynen et al., 2009). 
Second, their mode of action is dependent on the ligand bound, at least in the case of 
OSBP. While cholesterol-bound OSBP regulated scaffolding of a protein phosphatase 
complex regulating ERK signaling, upon 25-OHC binding the complex was 
dissociated, accompanied with ERK activation (Wang et al., 2005). 25-OHC binding 
by OSBP also mediates activation of cellular sphingomyelin synthesis by recruitment 
of CERT to Golgi (Perry and Ridgway, 2006). Moreover, manipulation of cellular 
sterols changed the positioning of LE, an effect regulated by ORP1L on the surface of 
LE (Rocha et al., 2009). It is likely that similar sterol sensor functions will be revealed 
for other ORP family members.  
2.3.5 The impacts of ORPs on cell signaling  
In addition to regulation of ERK signaling (discussed in the previous section), a 
second signaling function has been described for OSBP. Profilin-1, a protein 
regulating cytoskeletal architecture is upregulated upon stimulation with 7-KC. The 
aortic endothelium of diabetic humans expresses increased levels of profilin-1, which 
contributes to endothelial dysfunction. Furthermore, elevated profiling-1 levels were 
detected in atherosclerotic plaques compared to adjacent tissue (Romeo et al., 2004). 
OSBP was shown to mediate the 7-KC induced upregulation of profilin-1 in a process 
where OSBP is phosphorylated by Janus tyrosine kinase-2 (JAK-2), followed by 
activation of Signal Transducer and Activator of Transcription-3 (STAT3) (Romeo 
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and Kazlauskas, 2008). Analogous lipid-specific cell signaling functions probably 
exist for other ORP family members as well.  
 
PIPs are key components in the communication of cellular compartments and 
play central roles in a multitude of cellular processes (see section 2.1.5.1). Capability 
to interact with PIPs, via PHD, ORD, or both, seems to be a common property of the 
ORPs. Different PIP species are enriched in specific subcellular locations, acting as 
landmarks and functional regulators for ORPs and other cytosolic proteins that are 
recruited to membranes (Downes et al., 2005), (Figure 3). Of note, Osh-mediated in 
vitro sterol transfer is dependent on the PIP composition of the lipid vesicles used 
(Schulz et al., 2009).  
 
On the other hand, ORPs can also modify the cellular levels PIPs. In addition to the 
suggested function in sterol/PI4P exchange between membranes (de Saint-Jean et al., 
2011), Osh4p has been shown to affect the levels and availability of PI4P in the Golgi 
by inhibiting phosphatidylinositol 4-kinase Pik1p (Fairn et al., 2007). Osh3p in turn 
was shown to reduce the PM PI4P content, by facilitating the formation of MCS and 
activation of the ER PIP phosphatase Sac1 (Stefan et al., 2011).  
 
These examples imply that, by modulating the PIP metabolism, the ORPs could 
impact a variety of signaling processes. Furthermore, lipid rafts (section 2.1.2) have 
an established role in signal transduction processes (Lingwood and Simons, 2010). 
Cholesterol is an essential constituent of the lipid rafts, and the altered distribution 
or levels of cholesterol modify raft formation. Reports showing altered sterol 
distribution (Beh and Rine, 2004) or intracellular sterol transport (Hynynen et al., 
2005; Jansen et al., 2010) by ORP manipulation point out the possibility that ORPs 
could modify signaling by modification of lipid drafts. Interestingly, ORPs have been 
suggested to affect the ability of membranes to sequester sterols (Georgiev et al., 
2011; Sullivan et al., 2006).  
2.3.6 ORP proteins as modulators of membrane contact sites 
A key feature in the structure of many ORPs is the presence of several 
domains/motifs to regulate protein localization and protein-protein/protein-lipid 
interactions (section 2.3 and Figure 4). Furthermore, most ORPs contain either a 
FFAT motif to mediate interaction with ER VAP proteins (Loewen et al., 2003), or an 
ER-anchor (transmembrane) domain (Du et al., 2011; Yan et al., 2008), suggesting 
that interaction with the ER is a unifying feature of the ORPs and important for their 
function. Altered protein localization and/or function has been described for ORPs 
with the FFAT motif inactivated (Hynynen et al., 2009; Loewen et al., 2003), 
demonstrating the functional importance of the domain.  
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These features enable ORPs to bind two membranes simultaneously, which has 
prompted a speculation whether ORPs could be enriched at junctions where ER 
membranes are at close apposition of other cellular membranes, at so-called MCSs 
(Levine and Loewen, 2006). At these junctions, signals and small molecules, 
including lipids and calcium, are transferred between compartments (Toulmay and 
Prinz, 2011). Due to shorter distance between the organelles (10-30 nm), lipid 
transfer could be faster and more efficient at MCS. Interestingly, 4 out of 7 Osh 
proteins were shown to be enriched at sites where two organelles are closely 
apposed (Schulz et al., 2009). Osh1p is localized to NVJ, but is not necessary for the 
NVJ formation (Kvam and Goldfarb, 2004). Moreover, Osh3p activates Sac1 at ER-PM 
junctions to control PM PI4P levels (Stefan et al., 2011).  
 
Several studies support also the MCS localization and function of mammalian 
ORPs. OSBP localizes at ER-Golgi junctions to control the levels of PI4P, DAG, and SM 
at the Golgi membranes, essential for Golgi structure and function (Peretti et al., 
2008). ORP1L was described to control the motor recruitment at the ER-LE 
interphase in a cholesterol-dependent manner (Rocha et al., 2009). Knockdown of 
ORP5, an ER-anchored protein, resulted in cholesterol accumulation in LE/LYs (Du et 
al., 2011). Moreover, ORP5 was shown to co-immunoprecipitate with NPC1, a protein 
involved in cholesterol removal from the lysosomes. Accordingly, ORP5 was 
proposed to act at transient contact sites, where cholesterol is transported from 
lysosomes to the ER.  
 
These findings highlight the potential role of ORPs at MCSs. It is however unclear, 
whether the proteins mediate the MCS formation, function as transporters, or 
execute regulatory functions at these sites.  
2.3.7 ORP members enriched in macrophages 
Although ubiquitously expressed, ORP isoforms show a high degree of tissue and 
cell type specificity in their expression patterns (Lehto et al., 2001). In macrophages, 
in culture, in human coronary lesions, or both, three ORPs (ORP1L, ORP3, and ORP8) 
are expressed at high levels. The OSBPL1 gene encodes for two proteins, ORP1L and 
ORP1S, of which ORP1L is highly expressed in macrophages, brain, and lung 
(Johansson et al., 2003). The expression of ORP1L during monocyte to macrophage 
differentiation is heavily (100-160-fold) upregulated, suggesting a macrophage-
specific function (Johansson et al., 2003).  
 
ORP3 shows highest expression in the kidney, lymph nodes and thymus (Lehto et 
al., 2004), and high ORP3 levels in blood leukocytes, including macrophages, T cells, 
and B cells, have been observed, together with a moderate upregulation upon 
macrophage differentiation (Johansson et al., 2003). Moreover, ORP3 is highly 
expressed in certain forms of cancer. 
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ORP8 is most abundantly expressed in the liver, spleen, kidney, adipose tissue, 
and macrophages (Yan et al., 2008). Moreover, ORP8 mRNA levels in macrophages 
from advanced atherosclerotic lesions were approximately 3-fold higher as 
compared to a healthy arterial wall.  
2.3.7.1 ORP1L   
ORP1L localizes to the surface of LEs. Overexpression of ORP1L results in altered 
MVB/LE morphology: LEs were enlarged, abnormally full of internal membranes, 
and tended to cluster in the perinuclear area (Johansson et al., 2003). The ORP1L LE 
localization is determined by three N-terminal ankyrin repeats, but a protein 
containing both the ankyrin repeats and the PHD displays an enhanced LE 
localization and clustering phenotype is enhanced. In LE, ORP1L is part of a tripartite 
complex together with Rab7 and Rab7-interacting lysosomal protein (RILP) that acts 
to recruit a dynein/dynactin motor protein assembly to the surface of LE, followed 
by the transport of LE along cellular microtubule tracks in the minus-end direction, 
towards the cell center (Johansson et al., 2005, 2007). The minus-end directed 
transport of LE results from a cascade, a part of which is an interaction of dynein and 
betaIII spectrin, apparently facilitated by ORP1L (Johansson et al., 2007).  
 
To characterize cellular ORP1L ligands photo-crosslinking and in vitro pull-down 
assays employing purified protein have been used. In a liposome pull-down assay, 
the PHD binds several PIPs with a low affinity and specificity (Johansson et al., 2005). 
Photo-crosslinking experiments suggested the ORP1L ORD is capable of binding both 
cholesterol and 25-OHC (Suchanek et al., 2007).  Affinities for 22(R)-OHC and 25-
OHC have also been confirmed with in vitro pull-down assays (Yan et al., 2007a).  
 
Interestingly, macrophages overexpressing human ORP1L displayed reduced 
ABCG1 mediated cholesterol efflux to HDL2 acceptors, and caused an increased 
susceptibility to atherosclerotic lesion development after bone marrow 
transplantation into LDL receptor knockout (LDLr-/-) mice (Yan et al., 2007a)., an 
established mouse model for atherosclerosis Furthermore, IL-1β and phospholipid 
transfer protein (PLTP) mRNA levels, and PLTP activity were increased. The authors 
provided two possible explanations for the increased atherosclerosis susceptibility. 
First, altered expression of LXR target genes could result from increased ORP1L 
oxysterol binding. In addition to lipid metabolism related genes, LXRs reciprocally 
regulate inflammatory gene responses (Joseph et al., 2003; Shibata and Glass, 2009; 
Zelcer and Tontonoz, 2006). The observed decrease in ABCG1 mRNA and subsequent 
inhibition of cholesterol efflux, together with the increased pro-inflammatory IL-1β 
expression, are in line with altered LXR target expression, as suggested. On the other 
hand, the inhibition of cholesterol efflux could result from a disturbance of endocytic 
cholesterol transport caused by ORP1L.    
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2.3.7.2 ORP3  
Cellular localization of ORP3 results from a complex interplay between the PHD, 
ORD and FFAT domain. Our group has shown earlier that the main targeting 
determinants in the ORP3 structure are the FFAT motif, responsible for ER targeting, 
and the PHD, that targets the protein to PM (Lehto et al., 2005). In addition to the 
FFAT motif, a second ER targeting segment (encoded by exons 10 and 11), was also 
characterized. The role of ORD was suggested to be negative regulation of PM 
targeting. Moreover, ORP3 localization responded to the cellular lipid status: after 3 
days lipid starvation ORP3 localization to ER structures close to the PM was 
enhanced.  
 
Using purified protein to pull-down PIP containing liposomes, the ORP3 PHD was 
shown to bind PI(3,4,5)P3 and PI(3,4)P2 with highest affinity, and towards other PIP2 
species with moderate affinity (Lehto et al., 2005). For ORP3 ORD, for which binding 
of cholesterol and 25-OHC have been suggested by photo-crosslinking experiments 
(Suchanek et al., 2007), no other ligands have been identified. Moreover, 25-OHC 
treatment failed to induce ORP3 translocation, while a clear shift to the PM vicinity 
was observed for ORP3:OSBP chimeric protein, where ORP3 ORD was replaced with 
that of OSBP, capable of responding to stimulus by this oxysterol (Lehto et al., 2005).  
 
Consistent with the role of some ORPs in cell signaling, ORP3 was originally 
identified as a candidate interaction partner for the small GTPase R-Ras (Goldfinger 
et al., 2007). Moreover, the role of ORP3 in R-Ras regulated events (Kinbara et al., 
2003), including cell adhesion and spreading, organization of the actin cytoskeleton, 
β1-integrin activity and macrophage phagocytic function was demonstrated (Lehto 
et al., 2008). In HEK293 cells silencing of ORP3 resulted in impaired cell adhesion, 
enhanced spreading, and increased β1 integrin activity, while overexpression 
increased formation of cellular protrusions, at where ORP3 colocalized with R-Ras at 
the ends. Interestingly, R-Ras has also been implicated to promote neurite outgrowth 
(Oinuma et al., 2007). ORP3 was further shown to be phosphorylated upon loss of 
cell adhesion and by stimulation of PKC activators phorbol-12-myristate-13-acetate 
(PMA) and all-trans retinoic acid (ATRA). Interestingly, induction of phosphorylation 
enhanced the protrusion formation, suggesting ORP3 localizing at the protrusion tips 
is the phosphorylated form of ORP3. Conclusions on the effect of ORP3 
phosphorylation to R-Ras interaction could not be drawn based on this study.  
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2.3.7.3 ORP8   
A transmembrane span at the ORP8 C-terminus anchors the protein to the ER and 
nuclear membrane (Yan et al., 2008). Similar to ORP1 and ORP3, ORP8 ORD was by 
photo-crosslinking suggested to bind both cholesterol and 25-OHC (Suchanek et al., 
2007). In vitro experiments confirmed cholesterol binding and a weak affinity 
towards 25-OHC (Yan et al., 2008; Zhou et al., 2011). Other lipid ligands have not 
been confirmed and the PIP binding capacity/specificity of ORP8 PHD is unknown.  
 
Recently, ORP8 was shown to interact with Nucleoporin p62 (NUP62) at the 
nuclear membrane (Zhou et al., 2011). NUP62 is part of the nuclear pore complex, 
which dynamically regulates nucleo-cytoplasmic transport (Tran and Wente, 2006). 
Adenoviral overexpression of ORP8 in mouse liver markedly decreased cholesterol, 
TAG and PL in plasma and liver tissue (Zhou et al., 2011). A reduction in nuclear 
SREBPs and their target gene expression was concomitantly observed. Moreover, the 
effect of ORP8 on nuclear SREBPs and their target genes was inhibited by NUP62 
knockdown, suggesting that ORP8 may together with NUP62 control the nuclear 
transport of SREBPs.   
 
Earlier studies have shown that ORP8 silencing in the human THP-1 macrophages 
enhances the expression of ABCA1 and subsequent cholesterol efflux to apo-AI, 
whereas no effect in ABCG1 expression or cholesterol efflux to HDL2 was observed 
(Yan et al., 2008). These effects were suggested to be mediated, in part, by LXR 
together with E-box regulatory elements present in ABCA1 promoter.  
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Aims  
The aim of this thesis project was to study the role of three oxysterol binding 
protein (OSBP) related proteins (ORP1L, ORP3, and ORP8) in macrophages and to 
further characterize these proteins.   
 
 
 
The specific aims were the following: 
 
1. To find novel ligands and interaction partners for the ORPs 
 
2. To study the subcellular targeting of these proteins.  
 
3. To clarify the cellular function of these proteins.   
 
4. To study the impacts of ORP silencing on macrophage functions and their 
lipidome.  
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Materials and methods 
Listed below are described the methods used in the studies that were personally 
performed by me. The Roman numeral refers to the original publication.  
Cell culture and transfection (I, II, III) 
Human embryonic kidney HEK293, Huh7 hepatoma cells, and HeLa cell lines 
were cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 
10% fetal bovine serum (FBS), 100 U/ml penicillin, and 100 μg/ml streptomycin. For 
mouse macrophage RAW264.7 cell line culture medium contained additionally 10 
mM Hepes. For some experiments, RAW264.7 cells were maintained in macrophage 
serum-free medium (M-SFM, Gibco) supplemented with 10 ng/ml macrophage 
colony-stimulating factor (M-CSF, Invitrogen).   
 
Transfection of cells with cDNA was performed using Lipofectamine2000 
(Invitrogen), FugeneHD (Roche) reagents, or Amaxa nucleofection system (Lonza) 
according to manufacturer's instructions. HiPerFect transfection reagent (Qiagen) 
was used to transfect short interfering RNAs (siRNA).  
Lentiviral transduction and generation of stably silenced cell pools (I, II, III) 
Lentiviruses encoding for short-hairpin RNA (shRNA) against mouse ORP1L, 
ORP3, and ORP8 were from Sigma MISSION® TRC-Mm 1.0 (Mouse) shRNA library. 
Stably silenced cell pools were generated by transducing lentiviruses into RAW264.7 
cells with multiplicity of infection (MOI) 4 in the presence of 8 μg/ml hexadimethrine 
bromide. Selection of transduced cells was carried out in the presence of 4 μg/ml 
puromycin. Out of five shRNA constructs for each gene, two with the best silencing 
efficiency compared to Non-Targeting shRNA (shNT) control were used in further 
experiments. The silencing efficiency, determined by quantitative real-time 
polymerase chain reaction (qPCR), was monitored up to 20 passages.  
Purification of recombinant proteins and lipid binding assays (I) 
Glutathione-S-transferase (GST) proteins were produced in E. coli BL21(DE3) and 
purified using Glutathione-Sepharose 4B (GE Healthcare) using standard methods.  
 
In vitro oxysterol binding assays were performed as described in (Hynynen et al., 
2009). Briefly, 40 nM [3H]-labeled oxysterol were incubated overnight with 500 nM 
of purified ORP1L-GST or GST protein in the presence or absence of 1-50 fold molar 
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excess of competing oxysterol. The unbound sterol was then removed with charcoal-
dextran, and the amount of protein-bound [3H]-labeled oxysterol was analyzed by 
liquid scintillation counting.  
 
In vitro cholesterol binding assays were performed by preparing large 
unilamellar vesicles containing 0.5 mM PC with 1 mol% [3H]cholesterol as in (Ngo 
and Ridgway, 2009). The prepared vesicles were incubated with GST-ORP1S or GST 
(1:1 mol protein/mol sterol) for 30 min at 25°C. Liposomes were then 
ultracentrifuged at 100,000 g for 25 min at 4°C and the radioactivity of the 
supernatant was measured by liquid scintillation counting.  
Coimmunoprecipitation (I) 
Co-IP experiments were performed as described in (Johansson and Olkkonen, 
2005). HeLa cells transfected with Rab7-Xpress and ORP1L fused to green 
fluorescent protein GFP) constructs were scraped into 500 μl of lysis buffer (10 mM 
Hepes pH 7.6, 150 mM NaCl, 0.5 mM MgCl2, 10% glycerol, 0.5% Triton X-100, and 
protease inhibitor cocktail), kept on ice for 15 min, centrifuged for 15 min at 16,000 g 
at 4°C. The supernatants were precleared with Protein G-Sepharose 4 fast flow 
(Amersham) slurry for 30 min, and the supernatants were subsequently incubated 
with Xpress or control antibodies overnight at 4°C. Protein G-Sepharose 4 fast flow 
was then added to the mixture for 4 hours, followed by assaying of the bound 
immunocomplexes by Western blotting using ORP1L or Xpress antibodies.  
Labeling of cells with fluorescent probes (I) 
To analyze endocytic functionality, HeLa cells were incubated with rhodamine-
labeled epidermal growth factor (EGF, Molecular Probes) at 200 ng/ml for 1 h, 
followed by washes and chase up to 6 hours before fixation. Prior to labeling the cells 
were incubated for 1 hour in DMEM supplemented with 2 mg/ml bovine serum 
albumin and 10 mM Hepes. RAW264.7 macrophages were labeled with DiI-acLDL in 
serum-free medium for 1 hour at 50 μg/ml concentration. Fixed cells were then 
processed for immunofluorescence microscopy for further analysis.  
Fluorescence microscopy and image analysis (I, II) 
Cells grown on coverslips were fixed with 4% formaldehyde/PBS for 30 min, 
followed by 5 min permeabilization with 0.05% Triton X-100/PBS. Nonspecific 
binding was blocked with 10% FBS/PBS for 30 min, followed by antibody 
incubations in 5% FBS/PBS (at 37°C for 30 min). Antibodies were visualized with 
Alexa Fluor secondary antibody conjugates (Invitrogen). Cells were mounted in 
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Mowiol (Calbiochem) containing 50 mg/ml 1,4-diazocyclo-[2,2,2]octane (Sigma-
Aldrich). Coverslips were viewed with Leica SP2 confocal microscope, equipped with 
63x/NA 1.40 HCX PL APO CS (oil) Leica objective lens, or Zeiss AxioObserver Z1 
microscope, equipped with AxioCam HRm Rev.3 FireWire camera, and Plan-
Apochromat 63x/1.40 Oil M27 (oil) or EC Plan-Neofluar 40x/0.75 WD=0.71 M27 
objective. The acquisition softwares used were Leica LCS and AxioVision Rel. 4.8. 
Adobe Photoshop and Image J softwares were used for image processing.  
Labeling of cells with radioactive cholesterol and lipid analysis (I, III) 
RAW264.7 macrophages were loaded with 25 μg/ml [3H]-cholesterol oleate 
containing acLDL in the presence of 5% lipoprotein-deficient serum (isolated from 
FBS by buoyant density centrifugation) for 48 hours.  
To analyze cellular cholesterol efflux, medium was replaced after loading. The 
amount of radioactivity effluxed to the medium containing the cholesterol acceptors, 
apo-AI (10 μg/ml) or HDL2 (25 μg/ml), was determined with liquid scintillation 
counter.  
To analyze cellular lipids, cells were washed extensively with PBS before scraping 
into 0.2% SDS, and extracted using Bligh and Dyer method (Bligh and Dyer, 1959), 
followed by thin-layer chromatography on silica-gel plates by using petroleum 
ether/diethyl ether/acetic acid (60:40:1) as the solvent, as described in (Perttilä et 
al., 2009), or mass spectrometry.   
Quantitative real-time PCR (I, II, III) 
Total cellular RNA isolation was performed with RNeasy Mini kit (Qiagen). RNA 
(1 μg) was reverse-transcribed using random hexamer primers and Superscript III 
(Invitrogen).  
For qPCR each RNA sample was analyzed with SYBR Green kit (Applied 
Biosystems or Finnzymes) and 7000 Sequence Detection System in triplicates for the 
genes of interest together with housekeeping markers (ribosomal protein 36B4 and 
Porphobilinogen Deaminase PBGD) for normalization. Relative mRNA quantitations 
were determined by setting the threshold in the linear range of fluorescence to get 
the threshold cycle (Ct) for each well, and calculated by the comparative Ct method. 
Migration assays (II) 
To induce migration, 1 nM N-formylmethionyl-leucyl-phenylalanine (fMLP, 1 nM 
concentration) or sphingosine-1-phosphate (S1P, 1 μM) were used.  
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TranswellTM chambers (Corning) with 6.5 mm-diameter and 8 μm pore size were 
used for migration experiments. The cells in complete medium were added in the 
upper well and allowed to migrate to the lower compartment for 6 hours. Non-
migrant cells were washed, and cells at the bottom of the membrane were fixed, and 
stained with 0.1% Crystal Violet in 20% (v/v) methanol. After washing and drying of 
the membranes, the migrated cells were quantitated by dissolving the dye in 10% 
acetic acid, followed by a measurement of the dye intensity at 560 nm. Migration 
capacity was assessed as the ratio compared to total amount of cells seeded.  
 
For wound healing experiments, cells were grown on 6-well plates into 
confluency. The monolayers were then wounded with a pipette tip, followed by 
washing of detached cells with PBS. The wound closure was monitored up to 0-96 
hours with a bright-field EVOS xl microscope (AMG, Bothell, WA). 
 
Cellular migration capacity was additionally monitored by live-cell imaging. Cells 
were grown in glass-bottom dishes at low confluency, and imaged every 20 seconds 
by differential interphase contrast microscopy for a total of 30 minutes. 
Subcellular fractionation (II) 
To separate cellular nuclear and cytosolic fractions, cells were lysed in buffer 
containing 10 mM Hepes, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT, 0.05% NP40, pH 
7.9, and protease and phosphatase inhibitor cocktails (Roche). The fractions were 
separated by 10 min centrifugation at 3000 rpm at 4°C, where nuclear fraction was 
pelleted. Nuclear fraction was further homogenized in a buffer containing 5 mM 
Hepes, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 26% glycerol (v/v), pH 7.9, after 
adding 4.6 M NaCl. The fractions were analyzed by Western Blotting.  
SDS-PAGE and Western Blotting 
Cells were harvested in lysis buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 2 mM 
MgCl2, 10% glycerol, 0.5% NP-40) with protease inhibitor cocktail (Roche). Protein 
contents were determined by the detergent compatible (DC) protein assay (BioRad). 
Aliquots of 20 μg of the lysates were electrophoresed on Laemmli gels, followed by 
transfer to nitrocellulose membranes (Hybond-C Extra). Membranes were blocked 
for unspecific binding, followed by antibody incubations, all carried out in 5% (w/v) 
fat-free milk in TBS containing 0.01% Tween-20. The bound antibodies were 
visualized with HRP-conjugated goat IgG antibodies, and the ECL (Thermo Scientific, 
Rockford, IL). 
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Principal component analysis (III) 
To analyze the cellular lipidome data obtained by mass spectrometry, principal 
component analysis (Sirius program package) was used in the analysis of the cellular 
lipidome data.  Prior to the analysis, the molar percentages of lipid species were 
transformed logarithmically (arc sin) to prevent the abundant components from 
dominating in the analysis. The samples were plotted into biplots describing largest 
and second largest variance in the original multidimensional data. The statistical 
significance of the observations was assessed with soft independent modeling of 
class analogy (SIMCA, available in the Sirius software package). 
Other methods (I, II, III) 
All numerical data are presented as average ± stdev or s.e.m. for at least 3 
experiments. Depending on the experimental setup, the statistical significance of the 
data was assessed with Student's t-test (*p<0.05, **p<0.01, ***p<0.001) or with one-
way ANOVA (p<0.05), followed by Bonferroni’s test for differences between means. 
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 Results and discussion  
5.1 Subcellular targeting of ORPs -Lipid and protein interactions  
The hallmark feature of all ORPs is the presence of ORD (see section 2.3.1), 
present in all ORPs. Another noteworthy feature is the presence of several additional 
motifs, such as ankyrin repeats and PH domains. To understand the protein function, 
it is important to identify the lipid and protein interactions of the ORP proteins and 
to clarify the functional consequences of these interactions. In this work, several 
novel interactions with lipid ligands were identified and the roles of both known and 
novel interactions were further characterized.  
5.1.1 Novel ORP1L interactions  
5.1.1.1 ORP1L binds 24(S)-OHC, 7-KC and cholesterol in vitro (I) 
In the first part of this work, a competition assay was employed, where ORP1L 
binding to its established oxysterol ligand, 25-OHC (Yan et al., 2007a), was competed 
with other oxysterols. This assay identified two novel ORP1L oxysterol ligands, 
namely 24(S)-OHC, and 7-ketocholesterol (I, Figure 1A). With the experimental setup 
used, no differences in the binding affinities between oxysterols could be 
determined. The two newly identified oxysterol ligands are likely to have 
physiological importance. 7-ketocholesterol is an abundant oxysterol species in 
atherosclerotic lesions and macrophage foam cells (Garcia-Cruset et al., 2001; Maor 
et al., 2000), and the binding can thus be important in the context of atherogenesis. 
24(S)-OHC (also known as cerebrosterol) is the most abundant oxysterol in the CNS, 
and it is thought to be important for the cholesterol homeostasis of the brain (for 
review, see (Björkhem, 2007). This and the fact that ORP1L is expressed at high 
levels in the central nervous system (Johansson et al., 2003; Laitinen et al., 1999) 
suggest that ORP1L may play an important role in the cholesterol balance of the 
brain.  
 
In addition to oxysterols, cholesterol binding by ORP1L was demonstrated using 
an assay where the ability of purified ORP1 protein to extract cholesterol from large 
unilamellar vesicles, was determined. In this assay, ORP1 was able to extract 
cholesterol in a concentration-dependent manner (I, Figure 1B), similar to ORP2, 
included in the assay as a positive control (Hynynen et al., 2009). However, the 
affinities could not be compared between oxysterol and cholesterol binding due to 
the different experimental protocols used in these assays. Cholesterol is likely a 
physiologically important ORP1L ligand, as biological membranes are far more 
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enriched in cholesterol than oxysterols (Brown and Jessup, 1999). It is therefore 
possible that oxysterols are able to replace bound cholesterol from the sterol-binding 
pocket, serving as a trigger for protein activation or translocation, as described for 
OSBP, where binding of 25-OHC triggers disassembly of a protein phosphatase 
complex, induced by binding of cholesterol by OSBP (Wang et al., 2005, 2008).  
 
Whether there is a functional distinction between oxysterol and cholesterol 
binding of ORP1L, and whether it is a common feature of the ORPs, remain to be 
investigated in the future studies. Photo-crosslinking experiments have suggested 
that several ORPs (OSBP, ORP1, ORP2, ORP3, ORP5, ORP6, ORP7, ORP8, ORP10, 
ORP11) are capable of binding both 25-OHC and cholesterol (Suchanek et al., 2007).  
5.1.1.2 Recruitment of kinesin-2 and interaction of VAP by ORP1L (I) 
ORP1L has an established role as an effector protein of Rab7, and is involved in 
the minus-end directed transport of LE (Johansson et al., 2005, 2007). The minus-end 
directed transport of LE results from a cascade that involves recruitment of dynein-
dynactin motor complex to the surface of LE. In addition to its recruitment, dynein 
needs to interact with betaIII spectrin to translocate LE, a process dependent on 
ORP1L (Johansson et al., 2007). In (I), we show that in addition to the recruitment of 
dynein-dynactin complex to LE surface, ORP1L overexpression results in a drastic 
recruitment of a plus-end directed motor protein, kinesin-2, to the LE surface (I, 
Figure 3B). The recruitment of both plus- and minus-end motors to LEs was 
observed to comparable extent regardless of the endosome positioning. This result 
suggests that the regulation of LE motility is a complex process and that simple 
motor protein recruitment does not suffice for altering LE motility/distribution. The 
putative interaction of ORP1L with kinesin-2 was not examined in this study. 
Moreover, the inactivation of ORP1L FFAT motif and the resulting altered endosome 
localization and motility (I, Figure 4) suggests a functional interaction between 
ORP1L and VAP proteins.   
 
The role of ORP1L and its interactions in the LE motility will be further discussed 
in section 5.3.1.  
5.1.2 ORP3  
5.1.2.1 Kinases responsible for ORP3 phosphorylation 
ORP3 migrates in SDS PAGE as a double band, where the bands represent forms 
of the protein phosphorylated to various degrees (Lehto et al., 2008). The 
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phosphorylation is induced when cells upon trypsinisation and replating at a low 
density, when cells lose their contacts with adjacent cells and the environment.  
 
To identify the kinases catalyzing ORP3 phosphorylation, we performed a screen 
where human kinases predicted to have target sites in ORP3 sequence, were 
overexpressed in HEK293 cells, and the degree of the ORP3 phosphorylation was 
then monitored by Western blotting. Out of the 67 constructs tested, two kinases 
were able to induce a band shift in ORP3 (Figure 7), namely cyclic AMP dependent 
kinase PKA (catalytic subunit) and calcium/calmodulin dependent kinase CAMKII 
(several isoforms). These kinases are activated upon elevated cAMP or calcium 
levels, respectively. In contrast to previous studies where PMA, a PKC agonist, was 
able to induce ORP3 band shift, overexpression of PKC α, β, γ, δ, ε, ζ, ι, or ν subunits 
did not hyper-phosphorylate ORP3 (data not shown). It is, however possible that the 
subunits do not phosphorylate their targets as efficiently as single subunits.  
 
 
 Figure 7. The ORP3 band shift induced by kinase overexpression.  
5.2 Subcellular targeting of macrophage ORPs  
5.2.1 ORP1L LE localization does not involve ORD or FFAT domains (I) 
In the first part of this thesis, we generated several mutant forms of ORP1L to 
characterize the functionality of its ORD and FFAT motif. To elucidate the role of 
ORD, we deleted a four amino acid region (amino acids ELSK, 560-563). The leucine 
residue in this region is completely homologous in the protein family (data not 
shown), and the deletion of this area has been shown to result in deficient sterol 
binding for OSBP, ORP4, and ORP9 (Ngo and Ridgway, 2009; Perry and Ridgway, 
2006; Wyles et al., 2007). By homology modeling, we further showed that this leucine 
putatively interacts directly with the side chain of the bound sterol (I, Figure 1C). 
Moreover, deficient oxysterol binding of the ORP1L Δ560-563 mutant was 
demonstrated (I, Figure 1D-F). We were not able to assess, whether the mutant is 
able to bind cholesterol due to an anomalous behavior of the protein in the 
cholesterol-binding assay, most likely due to conformational changes putatively 
resulting in increased exposure of hydrophobic residues. Thus, it is possible that the 
mutant is not defective in cholesterol binding. Based on these binding assays, we 
concluded that the mutant served its purpose as a tool to study the function of ORP1L 
ORD.  
 
  
 
 
 
Results and discussion 
 
  
43 
Using fluorescence microscopy and double staining for endogenous markers 
(EEA-1 for EE, LAMP-1 for LE), we further showed that the ORP1L Δ560-563 
localized to LE membranes (I, Figure 2B), similar to the WT protein (I, Figure 2A). 
Additionally, ORP1L mFFAT (inactivated FFAT motif) and the double mutant ORP1L 
Δ560-563 mFFAT localized to LE membranes as well (I, Figure 4E,F). These studies 
are in line with previous results of Johansson et al. (Johansson et al., 2003), who 
demonstrated that ORP1L is targeted to LE membranes via N-terminal ankyrin 
repeats and PHD.  
5.2.2 ORP3 and VAP-A interact at the vicinity of plasma membrane 
To investigate the interaction of ORP3 and VAP-A, a bimolecular fluorescence 
complementation (BiFC) technique (Kerppola, 2006) was employed. Huh7 cells were 
transfected with N- and C-terminal fragments of the fluorescent protein Venus fused 
with ORP3 and VAP-A, respectively. The BiFC fluorescence arising upon interaction 
of the ORP3 and VAPA moieties in the cells was imaged. The two proteins were 
shown to interact at reticular ER locations. Interestingly, BiFC signals could be 
observed at patches associated with the plasma membrane (Figure 8). Since VAP-A is 
an integral ER protein, these patches could represent MCSs between PM and ER. 
Moreover, previous experiments where pull-down assays were employed to 
investigate the interaction of VAP-A and ORP3, suggested that the 
hyperphosphorylated ORP3 specifically interacts with VAP-A (Lehto et al., 2005). It 
will be interesting to study whether the ORP3 phosphorylation controls its 
association with VAP-A, or whether it controls MCS formation.  
 
 
 
 Figure 8. Bimolecular fluorescence complementation technique demonstrates interaction of ORP3 with 
VAP-A at the reticular ER and at patches at the PM (Left Figure). VAP-A (Middle Figure) was used as a 
cotransfection marker. The ORP3-VAP-A interaction at the PM is visualized in the right Figure where 
reticular ER signal (VAP-A) is subtracted from the BiFC signals (BiFC-VAPA). Figures by courtesy of 
Marion Weber-Boyvat (Minerva Institute).   
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5.2.3 ORP8  
To investigate the role of ORP8 ligand binding, a four amino acid region (Δ377-
380, DLSK) encompassing the conserved leucine residue was deleted. Deletion of this 
region has previously shown to result in deficient sterol binding in other ORP 
members (Ngo and Ridgway, 2009; Perry and Ridgway, 2006; Wyles et al., 2007) and 
ORP1L (section 5.2.1). To investigate the subcellular localization of the ORP8 Δ377-
380 mutant, HeLa cells overexpressing this mutant were analyzed by fluorescence 
microscopy. Interestingly, the ORP8 Δ377-380 protein was partially targeted to the 
PM, where patchy localization was evident (Figure 9). ORP8 has a transmembrane 
segment, shown to anchor ORP8 to the ER (Yan et al., 2008). Thus, the PM patches 
could represent PM-ER MCSs. To test this, ORP8 Δ377-380 was cotransfected with 
VAP-A (ER marker) and SNAP25 (PM marker) constructs. ORP8 Δ377-380 
colocalized with both of these markers at the PM (Figure 9A, B), suggesting that they 
are, in fact, MCSs. To investigate whether the WT protein also targets PM, ORP8 WT 
was cotransfected with SNAP25. Although majority of ORP8 appeared to localize at 
the reticular ER, as reported earlier, some localization was observed at the PM 
vicinity (Figure 9C, arrows). To further confirm PM localization of ORP8 Δ377-380, 
we used immunoelectron microscopy methods that provides resolution superior to 
light microscopy. HeLa cells transfected with ORP8 Δ377-380 GFP were processed 
for electron microscopy, and stained for GFP. Even though the signal is weak, the 
gold particles specifically localize at the vicinity of PM (Figure 9D).  
 
  
 
 
 
Results and discussion 
 
  
45 
 
  
Figure 9. A) Confocal microscopy images of HeLa cells transfected with ORP8 Δ377-380 GFP and VAP-A 
mCherry showing colocalization at the cell edges. B) Maximal projections of cells overexpressing ORP8 
Δ377-380 GFP and Snap25b mCherry demonstrating the plasma membrane localization of ORP8 Δ377-
380 GFP, and C) ORP8 WT. D) Immunoelectron microscopy of thin frozen sections of HeLa cells 
transfected with ORP8 Δ377-380 GFP, followed by detection with anti-GFP antibody and protein A-10 nm 
gold particles, confirm the plasma membrane proximity of ORP8 Δ377-380 GFP; Bars, 400 nm. EM figures 
by courtesy of Nils Bäck, University of Helsinki.  
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5.3 Function of ORPs and their impacts on cell physiology 
5.3.1 ORP1L regulates late endosome localization, motility, and function (I) 
In the first study of the thesis we characterized the ORD and the FFAT mutant of 
ORP1L. We demonstrated that even though these mutants localized to LE, the LE 
distribution was dramatically altered. Whereas overexpression of the WT protein 
induced perinuclear LE clustering, the ORP1L Δ560-563 decorated LEs were 
scattered within the cell (I, Figure 2B). A similar LE scattering phenotype was 
demonstrated by cellular cholesterol depletion (Rocha et al., 2009). We further 
demonstrated that there was no defect in the interaction between ORP1L Δ560-563 
and Rab7 (I, Figure 2D), and showed that the altered localization was not due to an 
inability to recruit motor complexes to LE surface that was, in fact, enhanced (I, 
Figure 3). Based on these two studies, ORP1L was suggested to act as a sterol sensor 
that regulates LE positioning. Furthermore, inactivation of the FFAT motif of ORP1L 
Δ560-563 mutant resulted in LE clustering, suggesting that this motif is bridging the 
LEs to ER via VAP interaction in the scattered phenotype. 
 
Importantly, using live cell imaging, we showed that the overexpression of ORP1L 
or any of its mutant forms resulted in reduced motility of late endosomal 
compartments compared to mock transfection (I, Figure 4A, red bars). Interestingly, 
ORP1L mFFAT decorated LE were significantly less immotile than the other ORP1L 
forms (I, Figure 4A, second green bar from the left), suggesting that the ER 
interaction restricts motility of these compartments. Silencing of ORP1L, on the other 
hand, had an opposite effect on LE motility: significantly increased motility of the LE 
compartments compared to control cells was shown (I, Figure 5B). Moreover, live 
cell imaging of the LE compartments in ORP1L silenced cells revealed that the LEs 
spent more time in the cell periphery, suggesting that the missing LE-ER interaction 
acts to reduce LE motility and to enhance LE centralization.  
 
To study whether the ORP1L overexpression or reduced motility affected the 
cargo handling of the LE compartments, fluorescently labeled EGF (rhodamine-EGF) 
was endocytosed, and the degradation was monitored by quantitating the amount of 
fluorescent signal. The degradative process was inhibited significantly by ORP1L 
overexpression, and the effect was even more pronounced for ORP1L Δ560-563 
mutant (I, Figure 6A). Due to the fact that the rhodamine-EGF accumulated vesicles 
were not positive for overexpressed ORP1L (I, Figure 6D,E), and the fact that 
silencing of ORP1L did not affect the EGF degradation (I, Figure 6B), we speculate 
that the effect of ORP1L on endosomal degradation is an indirect one.  
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5.3.2 The role of ORP1L in macrophage lipid transport and metabolism 
(I, III) 
To investigate the ORP1L mediated LE dynamics in a physiologically more 
relevant context, we used RAW264.7 macrophage cells silenced for ORP1L, where 
foam cell formation was induced by fluorescent acLDL (DiI-acLDL) internalization. 
Similarly to the previous results, live-cell imaging of the macrophages revealed 
increased motility of the lipid carrying compartments when ORP1L was silenced (I, 
Figure 7A). Moreover, a significant inhibition of cholesterol efflux to apo-AI acceptors 
was observed following loading of the cells with radioactively labeled acLDL (I, 
Figure 7B). This suggests that in these cells ABCA1 mediated cholesterol efflux is 
specifically affected, since ABCA1 preferably removes cholesterol from 
endolysosomal compartments (Azuma et al., 2009; Chen et al., 2001). Consistently, 
we observed a significant increase in both FC and CE levels in the lipidome analyses 
of the ORP1L silenced macrophages (III, Figure 2A) at basal situation, suggesting that 
the putative disturbance of vesicular lipid transport results in the accumulation of 
cellular cholesterol.  
 
In basal conditions a significant increase in cellular PI levels (III, Figure 4) and an 
altered PC composition (III, Figure 5), were observed. Cells silenced for ORP1L 
contained less short (30-32 carbon) and saturated PC species, and more 36-carbon 
PC species than the control cells. After LPS stimulation decreased PE-plasmalogen 
levels (PE-pl) were observed in ORP1L silenced cells (III, Figure 7). Plasmalogens are 
specific phospholipids that contain a vinyl ether moiety at the sn-1 position that is 
vulnerable to damage or oxidation. Plasmalogens are abundantly present in the PM 
and in lipid rafts (Pike et al., 2002), and they are suggested to act as membrane 
antioxidants preventing cholesterol oxidation in the PL bilayers (Maeba and Ueta, 
2003), although the evidence is controversial. Interestingly, oxidated plasmalogens 
are often detected in atherosclerotic lesions (Ford, 2010; Thukkani et al., 2003).  
 
These results indicate that ORP1L is an important player of macrophage lipid 
metabolism.  
5.3.3 Effects of ORP3 silencing on the macrophage lipidome (III) 
The specific effects of ORP3 silencing on the macrophage lipidome were fewer 
than what was observed for ORP1L or ORP8 silenced cells. A significant reduction of 
PI levels was observed both at basal and LPS stimulated conditions (III, Figure 4, 7), 
suggesting the role of ORP3 in the PI metabolism. Moreover, decreased levels of PE-
pl and glucosyl ceramides were observed (III, Figure 3C, 4, 7).  
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5.3.4 ORP8 specific effects on the macrophage lipidome (III) 
Similar to ORP1L, increased free and esterified cholesterol levels were observed 
in cells silenced for ORP8 (III, Figure 2A), consistent with the reported capacity of 
ORP8 to modify cholesterol levels in hepatic cells (Zhou et al., 2011). Moreover, 
decreased levels of PE-pl and glucosyl ceramides were observed (III, Figure 3C, 4), 
similar to ORP3. Significantly increased PE levels and decreased PI and PE-pl levels 
were observed after LPS stimulation (III, Figure 7). A moderate, non-significant 
increase in total LPC (III, Figure 7) together with significant increases in certain LPC 
species (III, Figure 8A) observed in ORP8 silenced cells after LPS treatment, could 
associate with macrophage inflammatory functions. These lipids act as signaling 
compounds in response to cell stimulation that activate G-protein coupled receptors, 
and regulate calcium homeostasis and migration (Meyer zu Heringdorf and Jakobs, 
2007). 
5.3.5 Silencing of ORP8 associates with altered nuclear functions and 
microtubule organization (II) 
The role of ORP8 in the modulation of lipid metabolism of macrophages and 
hepatic cells was earlier demonstrated (Yan et al., 2008; Zhou et al., 2011). In the 
second part of this thesis, we wanted to further investigate the function of ORP8 in 
macrophages; we performed a microarray transcriptome analysis of RAW264.7 
macrophage cells silenced for ORP8. Unexpectedly, a pathway analysis of the 
microarray results did not reveal significant changes in lipid metabolism pathways, 
but most prominently activated pathways were nuclear pathways (DNA metabolism 
and chromosome structure) together with centrosome and microtubule organization 
(II, Table 1). Most downregulated pathways involved lysosome function, growth 
factor activity and defense response. These changes in gene expression putatively 
indicate affected cell cycle control and proliferation. However, flow cytometric 
analysis did not reveal any significant changes in cell cycle progression between the 
control and the ORP8 silenced cells (II, Supplementary Figure 1A). Furthermore, the 
MTT assay did not reveal any differences in the proliferation capacity (II, 
Supplementary Figure 1A). 
5.3.6 Silencing of ORP8 enhances macrophage migration (II) 
The recently identified interaction between ORP8 and nucleoporin NUP62 (Zhou 
et al., 2011) led us to investigate the localization of NUP62 in ORP8 silenced cells by 
immunofluorescence staining of NUP62. In the control cells, NUP62 localizes evenly 
in the nuclear membranes. In cells silenced for ORP8, NUP62 displayed an abnormal 
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distribution with extensive intranuclear localization (II, Figure 4A), and could be 
seen in cytoplasmic vesicles and cell edges. Moreover, NUP62 was demonstrated to 
be upregulated in ORP8 silenced cells, and to display altered distribution between 
the nucleus and cytosol: a significantly increased proportion of NUP62 was found in 
the cytosolic cell fraction (II, Figure 4B,C).  
 
NUP62 has been shown to enhance cell migration in a process where NUP62 is 
recruited by the exocyst component EXO70 to the leading edge of migrating cells 
(Hubert et al., 2009). This and the increased amount of cytosolic NUP62 in ORP8 
silenced cells led us to investigate their capacity to migrate. Increased migration 
capacity was demonstrated by three distinct methods: through a porous filter, by a 
standard wound healing, and by live-cell imaging (II, Figure 5A, C, Supplementary 
videos 1-2). Furthermore, a functional connection between NUP62 and the increased 
migration phenotype in these cells was demonstrated by siRNA mediated NUP62 
knockdown, which returned the migration capacity to the level of control cell 
migration (II, Figure 5A).   
 
In the wound healing experiments and live-cell imaging, we observed more active 
formation of cell extensions, and more prominent lamellipodial formation. 
Lamellipodial formation requires reorganization of cytoskeletal elements, including 
actin and microtubules (Mogilner and Keren, 2009; Waterman-Storer et al., 1999). 
Indeed, microtubule organization was among the altered pathways in the 
transcriptome analysis. The staining of the microtubule cytoskeleton revealed longer 
microtubules extending to the cell periphery in cells silenced for ORP8 (II, Figure 
5D).  
 
Based on these results we hypothesized that, if NUP62 is recruited by EXO70 in 
migrating cells, increased interaction between NUP62 and EXO70 must exist in cells 
silenced for ORP8. Immunofluorescence analysis revealed frequent colocalization of 
NUP62 and EXO70 at the lamellipodial edges in ORP8 silenced cells (II, Figure 6A). 
Based on the fact that both EXO70 and ORP8 have been reported to bind the NUP62 
coiled-coil domain (Hubert et al., 2009; Zhou et al., 2011), we speculated that these 
two proteins could bind to NUP62 in a competitive manner, which we confirmed 
using an in vitro competition assay (II, Figure 6B).  
5.3.4 Common ORP impacts on the macrophage lipidome (III) 
In the third part of the study, distinct and complex effects on the cellular lipids 
were demonstrated for cells silenced for individual ORPs (sections 5.3.2-5.3.4). In 
addition, some lipidome features common for all ORP silenced cells were observed.  
 
All three studied ORPs affected cellular levels of total PIs at least in some 
conditions. At basal conditions, increased PI levels were observed in ORP1L silenced 
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cells, whereas a decrease in PI after LPS stimulus was observed when ORP3 or ORP8 
was silenced. PIs are present in the cytosolic side of cellular membranes and the 
phosphorylated forms (PIPs) are important for signaling (section 2.1.5.1). Moreover, 
majority of long ORP variants (ORP1L, ORP3, and ORP8 included) are capable of 
interacting with PIPs, and ORPs have been suggested to modify cellular PIP 
metabolism (see section 2.3.5, third paragraph).  
 
Similarly, cellular levels of total PE-pl were decreased by ORP silencing. At basal 
conditions, PE-pl levels were decreased in ORP3 and ORP8 silenced cells, and after 
LPS stimulus decreased levels were observed when ORP1L or ORP8 was silenced.   
 
Interestingly, after LPS treatment all cell pools silenced for ORPs were enriched in 
16-carbon sphingolipid species at the expense of the 24-carbon ones (III, Figure 6E). 
Moreover, an increase in ceramide levels was observed in ORP1L silenced cells (III, 
Figure 6C).  One of the major cellular responses of LPS-mediated TLR4 activation is a 
rise in ceramide levels (Dennis et al., 2010). This suggests that functional links 
between sphingolipid metabolism and the studied ORPs may exist. Cer synthases, 
responsible for producing a spectrum of different Cer species to be incorporated to 
various SM and glucosyl ceramides, show substrate chain length specificity (Merrill 
et al., 2007). Moreover, distribution of GPI-anchored proteins in rafts is affected by 
the SM chain length (Garner et al., 2007). The altered sphingolipid profiles indicate 
delicate alterations in the sphingolipid biosynthesis. Together with changes in the 
cellular FC and PE-pl contents, the properties of cholesterol/sphingolipid domains 
could be altered, and putatively result in modification of raft-dependent signaling. 
This is consistent with the hypotheses suggesting that the ORPs have the capacity to 
regulate lipid lateral organization (Georgiev et al., 2011; Sullivan et al., 2006).  
 
Another common trend was observed in the profiles of AA containing 
phospholipids (III, Figure 8A) that act as precursors for eicosanoids (section 2.1.5.4). 
Compared to the control cells, ORP silenced cells were enriched in AA containing PE 
and PC species, and displayed reduced amounts of AA containing PI species, while no 
difference in the total AA levels was observed. Due to the potent biological activity of 
eicosanoids, the AA levels, as well as their distribution among PL classes, are tightly 
controlled. AA is most readily released from PI stores (Astudillo et al., 2011). The 
decreased amount of PI-derived AA in cells silenced for ORPs may associate with 
dampened eicosanoid signaling.  
 
In addition to the altered AA distribution, significantly increased total levels of 
DHA containing phospholipids, precursors for resolvins (section 2.1.5.4), were 
observed in all the ORP silenced cells (III, Figure 8D). These results imply a capacity 
of the studied proteins to modify inflammatory responses, possibly by dampening 
eicosanoid production and enhancing resolvin production. 
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Conclusions 
 
In this study, macrophage-enriched ORP family members were investigated. 
Novel sterol ligands and protein interaction partners were identified, and the cellular 
targeting was investigated. Based on the data obtained, it can be concluded that these 
proteins perform distinct functions and act, for the most part, at distinct cellular 
compartments compared to one another. However, apparently all of the ORPs 
studied localize transiently at MCSs, and putatively mediate the formation of these 
sites. Moreover, their roles in the macrophage functions and lipid metabolism were 
demonstrated.   
 
The presence of several targeting domains or motifs is a key feature of long ORP 
variants (Figure 5), including the ones studied in this thesis. Moreover, their protein 
structure contains elements that target the proteins to ER membranes, either via 
interaction of ER VAP proteins, or via a transmembrane segment. In this study, 
localization at MCS was demonstrated for ORP1L (LE-ER), ORP3 (PM-ER), and ORP8 
(PM-ER). The signals mediating MCS formation, as well as the downstream effects 
differ between the proteins (Figure 10).  
 
 
 Figure 10. A scheme showing ORP protein at MCS together with putative functions. Some figure 
components were provided by Servier Medical Art (www.servier.com). 
ORP1L, which localizes at LE membranes, was demonstrated to mediate LE-ER 
interactions in a sterol-dependent manner (I), which was shown to be involved in the 
regulation of LE motility. However, it is likely that the control of LE motility is not the 
only function of these MCSs. For example, the maturation of LEs to multivesicular 
bodies (MVB) requires inward curvature of the vesicle membrane, a process 
putatively mediated by lipids. A recent study showed that knockdown of ORP1L in 
HeLa cells led to an impaired multivesicular body formation, which were 
dramatically increased in size and had significantly less intraluminal vesicles 
(Kobuna et al., 2010). The same phenotype was observed in C. elegans with depletion 
of ORPs or cholesterol, suggesting the involvement of ORP1L in mediating effects of 
cholesterol (or other lipids) in MVB formation (Kobuna et al., 2010). Thus, at ER-LE 
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contact sites, newly synthesized cholesterol could be transported from the ER to LEs, 
which could facilitate MVB formation. 
 
Targeting of ORP3 to PM or ER (Lehto et al., 2005) and its role as a regulator of 
cell adhesion (Lehto et al., 2008) have been reported. Here, ORP3 is shown to 
interact with VAP-A at patchy PM structures. Similarly ORP8, an integral ER-protein, 
is reported to localize at PM patches, which appears to be regulated by its ligand-
binding status. The functions of ORP3 and ORP8 at the ER-PM MCSs remain topics of 
future research. However, the patchy localization at the PM suggests a specific lipid 
lateral organization at these sites, and could represent lipid rafts.  
 
At least two events occurring at ER-PM MCSs have been described. Store-
operated calcium entry, activated upon depletion of ER calcium stores, requires a 
complex formation between ER-residing STIM (stromal interaction molecule) 
proteins and a PM-protein Orai1, to allow entry of calcium from extracellular sources 
(Shen et al., 2011). Moreover, the PM lipid composition determines targeting of 
STIM1: it preferentially enriches in lipid rafts (Pani and Singh, 2009). Interestingly, 
elevated calcium levels have been shown to associate with impaired cell viability 
induced by oxysterols (Kolsch et al., 1999). Thus, the possible regulation of cellular 
calcium levels by the ORPs remains an intriguing topic of future investigations.  
 
A tyrosine phosphatase PTP1B is suggested to act at ER-PM MCSs. This ER-
residing enzyme has been shown to bind several molecules at the PM, including PKC, 
tyrosine kinase Src, and insulin receptor (Anderie et al., 2007). ORP8 was previously 
shown to be required for insulin induced AKT activation and glucose homeostasis 
(Jordan et al., 2011); raising a possibility that ORP8 could function at the same 
complex with PTP1B.  
 
In previous reports and in this thesis the roles of ORPs the regulation of essential 
macrophage processes, including lipid metabolism, cholesterol trafficking, 
inflammatory response, phagocytosis, and migration, have been demonstrated. 
Macrophages play key roles in all stages of atherosclerotic lesion development, as 
discussed in section 2.2.2.  Accordingly, the modulation of ORP levels and/or function 
represents an attractive target for prevention or treatment of atherosclerosis.    
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